520 related articles for article (PubMed ID: 9328369)
1. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
2. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
3. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
4. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
[TBL] [Abstract][Full Text] [Related]
5. Mathematical approach for estimating iron needs in hemodialysis patients on erythropoietin therapy.
Tarng DC; Huang TP; Chen TW
Am J Nephrol; 1997; 17(2):158-64. PubMed ID: 9096447
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen.
Beguin Y; Loo M; R'Zik S; Sautois B; Lejeune F; Rorive G; Fillet G
Blood; 1993 Oct; 82(7):2010-6. PubMed ID: 8400253
[TBL] [Abstract][Full Text] [Related]
7. Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients.
Shoji S; Inaba M; Tomosugi N; Okuno S; Ichii M; Yamakawa T; Kurihara S
Eur J Haematol; 2013 Mar; 90(3):237-44. PubMed ID: 23281632
[TBL] [Abstract][Full Text] [Related]
8. Variations in erythropoiesis and serum ferritin during erythropoietin therapy for anaemia of end-stage renal disease.
Barosi G; Merlo C; Palestra P; Liberato NL; Guarnone R; Di Dio F; Piazza V; Salvadeo A
Acta Haematol; 1993; 90(1):13-8. PubMed ID: 8237268
[TBL] [Abstract][Full Text] [Related]
9. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload.
Tarng DC; Huang TP; Chen TW; Yang WC
Kidney Int Suppl; 1999 Mar; 69():S107-18. PubMed ID: 10084294
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients.
Dittrich E; Schillinger M; Sunder-Plassmann G; Hörl WH; Vychytil A
Perit Dial Int; 2002; 22(1):60-6. PubMed ID: 11929146
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of reticulocyte hemoglobin content, percentage of hypochromic red blood cells, and ratio of serum transferrin receptor level/serum iron level as markers of iron-deficiency erythropoiesis in patients undergoing hemodialysis].
Hasegawa M; Kawamura N; Koide S; Murase M; Asano S; Toba T; Kushimoto H; Murakami K; Tomita M; Hasegawa H; Shikano M; Mizuno M; Funahashi N; Kawashima S; Sugiyama S
Nihon Jinzo Gakkai Shi; 2002; 44(5):453-63. PubMed ID: 12216478
[TBL] [Abstract][Full Text] [Related]
13. [Anemia in peritoneal dialysis patients].
Lausević M; Nesić V; Jovanović N; Stojimirović B
Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
[TBL] [Abstract][Full Text] [Related]
14. Soluble transferrin receptors and reticulocyte hemoglobin concentration in the assessment of iron deficiency in hemodialysis patients.
Fusaro M; Munaretto G; Spinello M; Rebeschini M; Amici G; Gallieni M; Piccoli A
J Nephrol; 2005; 18(1):72-9. PubMed ID: 15772926
[TBL] [Abstract][Full Text] [Related]
15. A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients.
Beerenhout C; Bekers O; Kooman JP; van der Sande FM; Leunissen KM
Nephron; 2002 Sep; 92(1):32-5. PubMed ID: 12187081
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptor assay and zinc protoporphyrin as markers of iron-deficient erythropoiesis in end-stage renal disease patients.
Baldus M; Walter H; Thies K; Anders C; Stein M; Hellstern P; Brass H
Clin Nephrol; 1998 Mar; 49(3):186-92. PubMed ID: 9543601
[TBL] [Abstract][Full Text] [Related]
17. Iron metabolism indices for early prediction of the response and resistance to erythropoietin therapy in maintenance hemodialysis patients.
Tarng DC; Chen TW; Huang TP
Am J Nephrol; 1995; 15(3):230-7. PubMed ID: 7618648
[TBL] [Abstract][Full Text] [Related]
18. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
Kurzawa T; Owczarek A; Strzelczyk JK; Gołąbek K; Wiczkowski A
Adv Clin Exp Med; 2016; 25(3):425-31. PubMed ID: 27629729
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of iron deficiency in chronic renal failure.
Fernández-Rodríguez AM; Guindeo-Casasús MC; Molero-Labarta T; Domínguez-Cabrera C; Hortal-Casc n L; Pérez-Borges P; Vega-Díaz N; Saavedra-Santana P; Palop-Cubillo L
Am J Kidney Dis; 1999 Sep; 34(3):508-13. PubMed ID: 10469862
[TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of the reticulocyte hemoglobin equivalent in chronic hemodialysis patients].
Eckhardt A; Freiberg MA; de la Fuente J; Douthat W; Capra R
Rev Fac Cien Med Univ Nac Cordoba; 2011; 68(2):51-5. PubMed ID: 22440657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
